Evidence map›Paper›PMID 39303891›Full record

ArticleThe Journal of allergy and clinical immunology2025

Serum cytokine panels in pediatric clinical practice.

Paul M Gallo, Jihwan Kim, Kevin O McNerney, Caroline Diorio, Caelin Foley, Laura Kagami, Kristina Wagner, Whitney L Petrosa, Hana Conlon, Kandace L Gollomp and 11 more

Abstract read
In one paragraph

Article in The Journal of allergy and clinical immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Paul M GalloDivision of Hematology, Children's Hospital of Philadelphia, Philadelphia, Pa; Immune Dysregulation Program, Children's Hospital of Philadelphia, Philadelphia, Pa. Electronic address: paul.gallo@childrenscolorado.org.
Jihwan KimDivision of Hematology, Children's Hospital of Philadelphia, Philadelphia, Pa; Immune Dysregulation Program, Children's Hospital of Philadelphia, Philadelphia, Pa.
Kevin O McNerneyDivision of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pa.
Caroline DiorioDivision of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pa.
Caelin FoleyDivision of Hematology, Children's Hospital of Philadelphia, Philadelphia, Pa.
Laura KagamiDepartment of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pa.
Kristina WagnerDepartment of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pa.
Whitney L PetrosaImmune Dysregulation Program, Children's Hospital of Philadelphia, Philadelphia, Pa.
Hana ConlonImmune Dysregulation Program, Children's Hospital of Philadelphia, Philadelphia, Pa.
Kandace L GollompDivision of Hematology, Children's Hospital of Philadelphia, Philadelphia, Pa; Immune Dysregulation Program, Children's Hospital of Philadelphia, Philadelphia, Pa.
Scott W CannaImmune Dysregulation Program, Children's Hospital of Philadelphia, Philadelphia, Pa; Division of Rheumatology, Children's Hospital of Philadelphia, Philadelphia, Pa.
Alix E SeifImmune Dysregulation Program, Children's Hospital of Philadelphia, Philadelphia, Pa; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pa.
Maire A ConradImmune Dysregulation Program, Children's Hospital of Philadelphia, Philadelphia, Pa; Division of Gastroenterology, Hepatology, and Nutrition, Children's Hospital of Philadelphia, Philadelphia, Pa.
Judith R KelsenImmune Dysregulation Program, Children's Hospital of Philadelphia, Philadelphia, Pa; Division of Gastroenterology, Hepatology, and Nutrition, Children's Hospital of Philadelphia, Philadelphia, Pa.
Neil RombergImmune Dysregulation Program, Children's Hospital of Philadelphia, Philadelphia, Pa; Division of Allergy and Immunology, Children's Hospital of Philadelphia, Philadelphia, Pa.
Hamid BassiriImmune Dysregulation Program, Children's Hospital of Philadelphia, Philadelphia, Pa; Division of Infectious Disease, Children's Hospital of Philadelphia, Philadelphia, Pa.
Kathleen E SullivanImmune Dysregulation Program, Children's Hospital of Philadelphia, Philadelphia, Pa; Division of Allergy and Immunology, Children's Hospital of Philadelphia, Philadelphia, Pa.
David T TeacheyImmune Dysregulation Program, Children's Hospital of Philadelphia, Philadelphia, Pa; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pa.
Michele E PaesslerImmune Dysregulation Program, Children's Hospital of Philadelphia, Philadelphia, Pa; Division of Pathology, Children's Hospital of Philadelphia, Philadelphia, Pa.
Edward M BehrensImmune Dysregulation Program, Children's Hospital of Philadelphia, Philadelphia, Pa; Division of Rheumatology, Children's Hospital of Philadelphia, Philadelphia, Pa.
Michele P LambertDivision of Hematology, Children's Hospital of Philadelphia, Philadelphia, Pa; Immune Dysregulation Program, Children's Hospital of Philadelphia, Philadelphia, Pa.

Funding

RED CELL HEMOGLOBIN RESEARCH TRAINING PROGRAMT32HL007150 · NHLBI · CHILDREN'S HOSP OF PHILADELPHIA · PI STELLA T CHOU, Mortimer Poncz · 1985 to 2026
$7.4M
Integration of genomics and transcriptomics to investigate biological pathways in very early onset IBDR01DK127044 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI KELSEN, JUDITH RACHEL · 2021 to 2025
$3.4M
Identifying Genomic and Microbial Contributions in Early Childhood-Inflammatory Bowel DiseaseK23DK119585 · NIDDK · CHILDREN'S HOSP OF PHILADELPHIA · PI CONRAD, MAIRE ABRAHAM · 2019 to 2023
$927k
NET stabilization: mechanistic and therapeutic studies studying the role of NETs in thromboinflammatory diseaseR00HL177830 · NHLBI · CHILDREN'S HOSP OF PHILADELPHIA · PI Kandace Gollomp · 2025 to 2026
$890k
NET stabilization: mechanistic and therapeutic studies in thromboinflammatory disodersK99HL156060 · NHLBI · CHILDREN'S HOSP OF PHILADELPHIA · PI GOLLOMP, KANDACE · 2021 to 2024
$656k
NHLBI NIH HHS K99 HL156060NHLBI NIH HHS R00 HL177830NHLBI NIH HHS T32 HL007150NIDDK NIH HHS K23 DK119585NIDDK NIH HHS R01 DK127044
6 · The paper itself

Abstract

backgroundCytokines are soluble signaling proteins that regulate inflammation and coordinate immune responses. Serum cytokine panels are increasingly used in medical practice, yet our understanding of cytokines as biomarkers for disease remains limited.

objectiveWe sought to analyze real-world single-center use of a multiplexed cytokine panel, correlate its results with diagnosis and severity, and explore its use in pediatric practice.

methodsA multiplexed cytokine panel, able to return same-day results, was implemented in April 2020 at the Children's Hospital of Philadelphia (Philadelphia, Pa) and its performance was validated for clinical use. Coded patient data were collected using the REDCap database, and correlations between cytokine levels and outcomes of interest were analyzed retrospectively.

resultsCytokine levels correlate with acuity of care, with patients admitted to the pediatric intensive care unit having the highest cytokine values. Patients with familial hemophagocytic lymphohistiocytosis (fHLH) showed prominent peaks in IFN-γ, IL-10, and TNF, whereas patients with sepsis exhibited high IL-6 and IL-8 with relatively modest IFN-γ. Cytokine release syndrome (CRS) after chimeric antigen receptor T-cell therapy often demonstrated pan-panel positivity at peak levels, with a similar pattern as that of fHLH. A ratio of [IFN-γ] + [IL-10]/[IL-6] + [IL-8] levels was able to distinguish fHLH and CRS from severe sepsis.

conclusionsCytokine levels correlate with severity of illness and can help differentiate between syndromes that present similarly, including fHLH and CRS compared with sepsis. Cytokine panels can be used as biomarkers to inform diagnosis and management decisions, but significant work remains to dissect complex clinical patterns of disease.

Indexed as

Cytokine Release SyndromeCytokinesLymphohistiocytosis, HemophagocyticSepsisAdolescentBiomarkersChildChild, PreschoolFemaleHumansInfantMaleRetrospective StudiesBiomarkersCytokinescytokine release syndromeCytokineshemophagocytic lymphohistiocytosisinflammation

Identifiers

PMID39303891
PMCPMC12502881

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.